Table 1.
Viral pathogens identified in isolation and in co-infection
| Virus identified | Single infection | Viral co-infection | Total cases (n = 143) |
|---|---|---|---|
| Rhinovirus | 6/31 (19%) | 25/31 (81%) | 31 (22%) |
| - RV-A | 18 | ||
| - RV-C | 13 | ||
| Adenovirus | 6/30 (20%) | 24/30 (80%) | 30 (21%) |
| Enterovirus | 12/29 (41%) | 16/28 (57%) | 28 (20%) |
| - Coxsackie A2 | 2 | ||
| - Coxsackie A4 | 5 | ||
| - Coxsackie A5 | 2 | ||
| - Coxsackie A6 | 5 | ||
| - Coxsackie A9 | 1 | ||
| - Coxsackie A14 | 1 | ||
| - Coxsackie B1 | 2 | ||
| - Coxsackie B2 | 2 | ||
| - Cosxackie B4 | 1 | ||
| - Echo6 | 2 | ||
| - Echo9 | 1 | ||
| - Echo14 | 1 | ||
| - Echo19 | 1 | ||
| - Echo30 | 1 | ||
| Influenza | 11/19 (58%) | 8/19 (42%) | 19 (13%) |
| - A/H3N2 | 13 | ||
| - A/H1N1 | 0 | ||
| - B | 6 | ||
| Human Herpesvirus 6 | 3/17 (18%) | 14/17 (82%) | 17 (12%) |
| Coronavirus | 2/13 (15%) | 11/13 (85%) | 13 (9%) |
| - HCOV-OC43 | 8 | ||
| - HCOV-NL63 | 2 | ||
| - HCOV-HKU1 | 2 | ||
| - HCOV0HL63 | 1 | ||
| Respiratory Syncytial Virus | 6/13 (46%) | 7/13 (54%) | 13 (9%) |
| - RSVA | 8 | ||
| - RSVB | 3 | ||
| Human Bocavirus | 2/13 (15%) | 11/13 (85%) | 13 (9%) |
| Parainfluenza III | 4/7 (57%) | 3/7 (43%) | 7 (5%) |
| Human metapneumovirus | 2/5 (40%) | 3/5 (60%) | 5 (3%) |